Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Mark Thursz, Louise Sarr et al.|The Lancet Global Health|2016Cited by 182
Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case–control study in The GambiaYusuke Shimakawa, Andrew Hall, Ousman Nyan et al.|Liver International|2015Cited by 41
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort studyGibril Ndow, Maud Lemoine, Zakary Warsop et al.|The Lancet Global Health|2023Cited by 32
Hepatitis B testing and treatment in HIV patients in The Gambia—Compliance with international guidelines and clinical outcomesGibril Ndow, Maud Lemoine, Mindy Gore et al.|PLoS ONE|2017Cited by 19
Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West AfricaGibril Ndow, Maud Lemoine, Damien Cohen et al.|The Journal of Infectious Diseases|2021Cited by 18